Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injury

Affiliations

• ¹ François-Rabelais University, School of Medicine, Tours, France.
• ² Tours University Hospital, Emergency Medicine Dept, Tours, France.
• ³ INSERM, U942, BIOmarkers in CArdioNeuroVAScular diseases, Paris, France.
• ⁴ Christchurch Heart Institute, Dept of Medicine, University of Otago, Christchurch, New Zealand.
• ⁵ Emergency Dept and Research Unit UR06SP21, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
• ⁶ Adnan Menderes University, Faculty of Medicine, Dept of Emergeny Medicine, Aydin, Turkey.
• ⁷ Cumhuriyet University, Faculty of Medicine, Dept of Cardiology, Sivas, Turkey.
• ⁸ Univ Paris Diderot, Sorbonne Paris Cité, Paris, France.
• ⁹ APHP, Saint Louis Lariboisière Hospitals, Dept of Anesthesiology and Critical Care, Paris, France.
• ¹⁰ Cardiology Dept, Hospital de la Santa CreuiSant Pau, Biomedical Research Institute IIB-SantPau, Universidad Autónoma de Barcelona, Barcelona, Spain.
• ¹¹ Dept of Internal Medicine, University Hospital, Basel, Switzerland.
• ¹² APHP, Saint Louis Lariboisière Hospitals, Emergency Medicine Dept, Paris, France.
• ¹³ Dept of Cardiology, Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, Lithuania.
• ¹⁴ Abbott Laboratories, Abbott Park, IL, USA.
• ¹⁵ Institute for Heart and Lung Health, Respiratory Division, University of British Columbia, Vancouver, BC, Canada.
• ¹⁶ APHP, Saint Louis Lariboisière Hospitals, Dept of Biochemistry, Paris, France.
• ¹⁷ UBC and VGH Divisions of Respiratory Medicine, Institute for Heart and Lung Health, Vancouver, BC, Canada.
• ¹⁸ Cardiovascular Research Institute, National University of Singapore, Singapore.
• ¹⁹ INSERM, U942, BIOmarkers in CArdioNeuroVAScular diseases, Paris, France alexandre.mebazaa@aphp.fr.
• ²⁰ Vilnius University, Vilnius, Lithuania.